Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
AAREYDRUGS
₹77.50
₹75.66
₹77.50
₹50.31
₹100.00
Markets Today
Historical Performance
As of 27-07-2026 01:14, Aarey Drugs & Pharmaceuticals Ltd. share price today is ₹0, with a change of ₹-77.20 (-100.00%) from the previous close of ₹77.2. The stock opened at ₹0 and traded between ₹75.66 and ₹77.5, with a total traded volume of 11763 shares. The company has a market capitalization of ₹218.9 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹100 and ₹50.31, respectively.
Aarey Drugs & Pharmaceuticals Ltd. valuation metrics include a P/E ratio of 48.4, and book value of ₹1.50. Profitability indicators show ROE of 2.63%. Aarey Drugs & Pharmaceuticals Ltd. has reported revenue of ₹472.27 Cr and net profit of ₹4.52 Cr.
Aarey Drugs & Pharmaceuticals Ltd. technical indicators include Day RSI at 40.26, Day MFI at 74.89, Day ADX at 27.4. Additional indicators include Commodity Channel Index (CCI) at -85.9 and Williams %R at -74.01. Momentum indicators show Day MACD at -2.12, Day MACD Signal Line at -1.22, DayATR at 2.55. Rate of Change indicators for Aarey Drugs & Pharmaceuticals Ltd. include ROC125 at 23.07 and ROC21 at -15.13.
Exponential moving averages include EMA5 at ₹77, EMA10 at ₹78.4, EMA12 at ₹79, EMA20 at ₹80.5, EMA26 at ₹81.1, EMA50 at ₹81.4, EMA100 at ₹79.6, EMA200 at ₹76.1. Simple moving averages include SMA5 at ₹76.3, SMA10 at ₹78, SMA20 at ₹83, SMA30 at ₹82.9, SMA50 at ₹82.5, SMA100 at ₹78.4, SMA150 at ₹74.9, SMA200 at ₹78.1.
Support levels for Aarey Drugs & Pharma are placed at First Support ₹75.38, Second Support ₹73.56, Third Support ₹72.65. Resistance levels are seen at First Resistance ₹78.11, Second Resistance ₹79.02, Third Resistance ₹80.84. Aarey Drugs & Pharmaceuticals Ltd. shareholding pattern shows promoter holding at 37.71%, FII holding at 4.81%, DII holding at 0%, public holding at 55.87%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 189.47 | 96.43 | 84.16 | 102.21 | 108.10 |
| Operating Expense | 185.13 | 97.94 | 81.52 | 100.51 | 112.95 |
| Operating Profit | 4.34 | -1.51 | 2.64 | 1.70 | -4.85 |
| Depreciation | 0.85 | 0.83 | 0.69 | 0.49 | -1.42 |
| Interest | 1.78 | 0.92 | 1.26 | 1.04 | 2.48 |
| Tax | -0.28 | 0.35 | 0.46 | 0.36 | 1.15 |
| Net Profit | 1.56 | 0.57 | 1.02 | 1.37 | 0.47 |
₹77.50
↗ Bullish Moving Average
4
↘ Bearish Moving Average
12
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 44.8 | 44.8 | 44.8 | 39.1 | 37.7 | 37.7 |
| FII | 2.3 | 2 | 1.1 | 3.9 | 4.2 | 4.8 |
| DII | 0 | 0 | 0 | 0 | 1.6 | 1.6 |
| Public | 52.9 | 53.2 | 54.1 | 57.1 | 56.5 | 55.9 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 7.34 K | 7.34 K | 100.00% |
| Week | 26.87 K | 26.87 K | 100.00% |
| 1 Month | 30.62 K | 30.62 K | 100.00% |
| 6 Month | 1.01 L | 1.48 L | 68.60% |
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Newly Affordable Stocks with Good Financials and Durability (subscription)
Consistent high performing stocks over Five Years
Mid-range Performer (DVM)
Companies with high TTM EPS Growth
PEG lower than Industry PEG
Good Aggregate Candlestick Strength (total bullish - bearish candlesticks)
Relative Outperformance versus Industry over 1 Week
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Increasing Revenue every quarter for the past 2 quarters
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Top Gainers
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 13 Dec, 2018 | 0.1 | INTERIM | 14 Dec, 2018 | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹539.10 | ₹5.25 | ₹163 | ₹15.10 | ₹506 | ₹61.75 |
| % Change | -0.11% | 1.55% | -1.81% | 0.13% | -2.65% | -0.82% |
| Revenue TTM (₹ Cr) | - | ₹69.99 | ₹287.68 | ₹176.50 | ₹502.55 | ₹237.47 |
| Net Profit TTM (₹ Cr) | - | ₹-176.47 | ₹14.88 | ₹27.81 | ₹57.92 | ₹-3.28 |
| PE TTM | - | -0.20 | 43.30 | 28.80 | 25.90 | -103.20 |
| 1 Year Return | 37.68 | 417 | 31.75 | 65.71 | -24.97 | -35.11 |
| ROCE | 3.56 | -56.37 | - | 17.36 | 23.87 | 0.77 |
Sigachi Industries Ltd.
₹ 25.50
-2.00%
Windlas Biotech Ltd.
₹ 856.00
-0.63%
Vineet Laboratories Ltd.
₹ 38.60
+3.21%
Solara Active Pharma Sciences Ltd.
₹ 495.00
-5.49%
Zim Laboratories Ltd.
₹ 120.40
+1.30%
Medico Remedies Ltd.
₹ 37.93
-0.94%
Dishman Carbogen Amcis Ltd.
₹ 183.41
+2.33%
Lasa Supergenerics Ltd.
₹ 6.97
-1.83%
Advanced Enzyme Technologies Ltd.
₹ 317.55
+1.05%
Bajaj Healthcare Ltd.
₹ 325.00
+2.30%
Ortin Global Ltd.
₹ 14.70
-1.41%
Brooks Laboratories Ltd.
₹ 64.40
-2.39%
RPG Life Sciences Ltd.
₹ 2970.00
+2.33%
Bafna Pharmaceuticals Ltd.
₹ 238.15
-2.00%
Alpa Laboratories Ltd.
₹ 66.33
-0.72%
SMS Pharmaceuticals Ltd.
₹ 385.95
+0.34%
Nectar Lifesciences Ltd.
₹ 10.30
-0.58%
Mangalam Drugs and Organics Ltd.
₹ 27.10
-0.26%
Indoco Remedies Ltd.
₹ 243.00
+2.04%
Ind-Swift Laboratories Ltd.
₹ 229.00
+1.33%
Lincoln Pharmaceuticals Ltd.
₹ 585.00
-0.39%
Panacea Biotec Ltd.
₹ 443.00
-0.54%
Medicamen Biotech Ltd.
₹ 243.00
+2.25%
Themis Medicare Ltd.
₹ 110.64
+2.64%
By signing up I certify terms, conditions & privacy policy